CF
LUCD icon

Cantor Fitzgerald’s Lucid Diagnostics LUCD Stock Holding History

Cantor Fitzgerald’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-264,653
Closed -$405K – 746
2022
Q3 		$405K Sell
264,653
-69,064
-21% -$172K 0.01% 533
2022
Q2 		$754K Hold
333,717
– – 0.01% 504
2022
Q1 		$1.12M Sell
333,717
-83,430
-20% -$305K 0.08% 182
2021
Q4 		$2.24M Buy
+417,147
New +$3.39M 0.16% 121

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cantor Fitzgerald's LUCD Position: Q4 2022 in Review

Cantor Fitzgerald sold out of Lucid Diagnostics (LUCD) in Q4 2022, closing a stake of 264,653 shares — an estimated $405K sold.

Cantor Fitzgerald first reported a position in LUCD in Q4 2021 and held it in 4 quarters. The position peaked at $2.24M in Q4 2021. 23 funds tracked by Wall St. Rank hold LUCD as of Q4 2022.

  • Cantor Fitzgerald reported no remaining Lucid Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Cantor Fitzgerald sold 264,653 Lucid Diagnostics shares in Q4 2022, an estimated $405K.
  • Cantor Fitzgerald first reported a position in Lucid Diagnostics in Q4 2021 and held it in 4 quarters.
  • Cantor Fitzgerald's Lucid Diagnostics position peaked at $2.24M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.